data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Nektar Therapeutics
(NASDAQ:NKTR)
$3.75
00
At close: Jul 1
$3.75
00
After Hours: 4:11PM EDT
Day High/Low- - -
52 Week High/Low3.02 - 19.37
Open / Close- / -
Float / Outstanding121M / 186.3M
Vol / Avg.- / 4M
Mkt Cap698.5M
P/E-
50d Avg. Price3.84
Div / Yield-
Payout Ratio-
EPS-0.49
Total Float121M

Nektar Therapeutics (NASDAQ:NKTR), Quotes and News Summary

Nektar Therapeutics (NASDAQ: NKTR)

Day High/Low- - -
52 Week High/Low3.02 - 19.37
Open / Close- / -
Float / Outstanding121M / 186.3M
Vol / Avg.- / 4M
Mkt Cap698.5M
P/E-
50d Avg. Price3.84
Div / Yield-
Payout Ratio-
EPS-0.49
Total Float121M
Benzinga - 3 days ago
Benzinga - 3 days ago
Benzinga - May 31, 2022, 9:12AM
Benzinga - May 23, 2022, 9:27AM
Benzinga - May 23, 2022, 9:26AM
Benzinga - May 5, 2022, 6:15PM
Benzinga - Apr 26, 2022, 11:43AM
Benzinga - Apr 25, 2022, 4:36PM
Benzinga - Apr 25, 2022, 4:35PM
Benzinga - Apr 18, 2022, 11:40AM
Benzinga - Apr 18, 2022, 10:02AM
Benzinga - Apr 18, 2022, 9:13AM
Benzinga - Apr 18, 2022, 8:49AM
Benzinga - Apr 18, 2022, 7:26AM
Benzinga - Apr 18, 2022, 7:22AM
Benzinga - Apr 14, 2022, 4:34PM
load more
Sector: Health Care.Industry: Pharmaceuticals
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, the company is focused on activating the immune system's natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.680-0.490 0.1900
REV24.380M24.822M442.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Nektar Therapeutics Questions & Answers

Q
How do I buy Nektar Therapeutics (NKTR) stock?
A

You can purchase shares of Nektar Therapeutics (NASDAQ: NKTR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Nektar Therapeutics's (NKTR) competitors?
Q
What is the target price for Nektar Therapeutics (NKTR) stock?
A

The latest price target for Nektar Therapeutics (NASDAQ: NKTR) was reported by Jefferies on Tuesday, May 31, 2022. The analyst firm set a price target for 4.00 expecting NKTR to rise to within 12 months (a possible 6.67% upside). 16 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Nektar Therapeutics (NKTR)?
A

The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $3.75 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Nektar Therapeutics (NKTR) pay a dividend?
A

There are no upcoming dividends for Nektar Therapeutics.

Q
When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?
A

Nektar Therapeutics’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Nektar Therapeutics (NKTR) going to split?
A

There is no upcoming split for Nektar Therapeutics.

Q
What sector and industry does Nektar Therapeutics (NKTR) operate in?
A

Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.